PET imaging of DNA damage using 89Zr-labelled anti-γH2AX-TAT immunoconjugates

被引:0
作者
James C. Knight
Caitríona Topping
Michael Mosley
Veerle Kersemans
Nadia Falzone
José M. Fernández-Varea
Bart Cornelissen
机构
[1] University of Oxford,CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology
[2] Royal Marsden Hospital,Facultat de Fisica (ECM and ICC)
[3] Universitat de Barcelona,undefined
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2015年 / 42卷
关键词
Zr; γH2AX; DNA damage; PET; TAT;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1707 / 1717
页数:10
相关论文
共 146 条
[21]  
Rogakou EP(2013)2013 SNMMI Highlights Lecture: oncology J Nucl Med 54 11N-22N
[22]  
Pilch DR(2008)PET versus SPECT: strengths, limitations and challenges Nucl Med Commun 29 193-207
[23]  
Orr AH(2008)DNA double-strand break repair of blood lymphocytes and normal tissues analysed in a preclinical mouse model: implications for radiosensitivity testing Clin Cancer Res 14 6546-6555
[24]  
Ivanova VS(2011)Prolonged expression of the γ-H2AX DNA repair biomarker correlates with excess acute and chronic toxicity from radiotherapy treatment Int J Cancer 129 2928-2934
[25]  
Bonner WM(2011)H2AX phosphorylation at the sites of DNA double-strand breaks in cultivated mammalian cells and tissues Clin Epigenetics 2 283-297
[26]  
Rothkamm K(2008)Utility of antiphosphorylated H2AX antibody (gamma-H2AX) in diagnosing metastatic renal cell carcinoma Appl Immunohistochem Mol Morphol 16 349-356
[27]  
Löbrich M(2013)Radiosensitivity in breast cancer assessed by the histone γ-H2AX and 53BP1 foci Radiat Oncol 8 98-174
[28]  
Bartkova J(2011)Recent developments in the use of γ-H2AX as a quantitative DNA double-strand break biomarker Aging 3 168-2482
[29]  
Horejsí Z(2013)Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest Cell Death Dis 4 e478-1025
[30]  
Koed K(2013)Targeting γH2AX during oncogenesis with Auger electron therapy delays tumor onset J Nucl Med 54 121-383